| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Vivo Ventures VI, LLC last filed a Form 4 in April 2015, as 10% Owner at KALV.
At the last filing, the largest reported position was 4,204,564 shares of KALV. Net of sales, the KALV filings show accumulation of 1,012,500 shares.
Vivo Ventures VI, LLC has 1 Form 4 filing on record in April 2015, as 10% Owner at KalVista Pharmaceuticals (KALV), 2015.
The 8 reported transactions were 6 conversions and 2 open-market purchases.
Counted by filing, the open-market trades come to 1 purchase worth about $5.1M and no sales.
The only open-market purchase was 1,012,500 shares of KALV at an average $5.00 on April 14, 2015, about $5.1M.
Shares as reported in the last Form 4 for each company; the most recent is from April 2015. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 14, 2015 | KALV Kalvista Pharmaceuticals, Inc. | 10% Owner | Buy | 1,012,500 | $5.00 | $5,062,500.00 | +31.7% |